Skip to main content

Together we are beating cancer

Donate now

Search Results: immunotherapy

Showing 12 out of 568 results
A male doctor and patient

The lung cancer immunotherapy drug pembrolizumab has been made widely available on the NHS in England after a price deal was reached. The lung cancer immunotherapy drug pembrolizumab has been made widely available on the NHS in England after a price deal was reached.

by Cancer Research UK | News | 6 June 2018

6 June 2018

Reovirus

Infecting tumours with viruses may boost the success of immunotherapy for brain and breast cancers, according to two new studies. Infecting tumours with viruses may boost the success of immunotherapy for brain and breast cancers, according to two new studies.

by Cancer Research UK | News | 3 January 2018

3 January 2018

The type of bacteria in the gut of patients with advanced melanoma may influence their response to a certain type immunotherapy, according to new research. The type of bacteria in the gut of patients with advanced melanoma may influence their response to a certain type immunotherapy, according to new research.

by Cancer Research UK | News | 2 November 2017

2 November 2017

Combining information from different cancer scans could offer a way to predict if immunotherapy will work, according to a small unpublished study. Combining information from different cancer scans could offer a way to predict if immunotherapy will work, according to a small unpublished study.

by Cancer Research UK | News | 27 October 2017

27 October 2017

New research suggests injury to the cells that line blood vessels could be behind severe side effects that some patients have after CAR T cell therapy. New research suggests injury to the cells that line blood vessels could be behind severe side effects that some patients have after CAR T cell therapy.

by In collaboration with PA Media Group | News | 13 October 2017

13 October 2017